First Successful In-Utero Stem Cell Therapy for Spina Bifida Shows Safety in Phase 1 Trial
By
gmays
Baker's choice. Dense with flavour, light on filler.
Summary
UC Davis Health researchers have successfully performed the world's first in-utero stem cell therapy for spina bifida repair, combining fetal surgery with human placenta-derived stem cells. The Phase 1 clinical trial results published in The Lancet demonstrate the treatment is safe and feasible, marking a significant advancement in prenatal medicine for this congenital condition where the spinal cord fails to close properly during fetal development.
Key quotes
· 4 pulledUC Davis Health research team has safely performed the world's first spina bifida treatment combining fetal surgery with stem cells
The study tested whether adding a layer of human placenta-derived stem cells to standard fetal surgery could be done safely
Spina bifida, also known as myelomeningocele, occurs when the spinal cord fails to close properly during fetal development
These results have been published today in The Lancet
You might also wanna read
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
Japanese researchers develop vitamin K-like compounds that may help convert brain cells into neurons
Japanese researchers have developed a new family of vitamin K-like molecules that may help immature brain cells transition into neurons. Whi
zmescience.com·1d agoInternational trial shows DNA test could help many breast cancer patients avoid chemotherapy
A new international trial presented at the American Society of Clinical Oncology conference suggests that millions of breast cancer patients

Cohort Study Evaluates Age at Onset and Family History as Predictors for Genetic Testing in Parkinson Disease
This cohort study evaluates the association between age at onset (AAO) and family history in Parkinson disease patients who carry pathogenic
